| Pharmaceutical active ingredients: |
| Oxybuprocaine Hydrochloride |
| Available forms, composition and doses of Novesine 1% KNO: |
| Solution; Ophthalmic; Oxybuprocaine Hydrochloride 0.4% |
| Novesine 1% KNO medical category: |
| Human:Local anesthetics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D04AB03 - OxybuprocaineS01HA02 - Oxybuprocaine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| NovartisBournonville Eumedica |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Noverty | Betahistine Mesylate | Novell Pharmaceutical Laboratories |
| Noveryl | Dibenzepin | Unidentified Pharmaceutical Company |
| Novesin | Oxybuprocaine Hydrochloride | Novartis; Adcock Ingram; OmniVision |
| Novesina | Oxybuprocaine Hydrochloride | Novartis |
| Novesine | Oxybuprocaine Hydrochloride | Novartis; Bournonville Eumedica; Merck; Wander |
| Novesinol | Oxybuprocaine Hydrochloride | Novartis |
| Novestrine | Methallenestril | Unidentified Pharmaceutical Company |
| Novestrol | Ethinyl Estradiol | Unidentified Pharmaceutical Company |
| Novex | Clorophene; O-Phenylphenol | NOVA Scientific |
| Novex Concentrate | Clorophene; O-Phenylphenol | NOVA Scientific |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nesopin | Oxybuprocaine Hydrochloride | Sintez |
| Novain | Oxybuprocaine Hydrochloride | Agepha |
| Novesin | Oxybuprocaine Hydrochloride | Novartis; Adcock Ingram; OmniVision |
| Novesina | Oxybuprocaine Hydrochloride | Novartis |
| Novesine | Oxybuprocaine Hydrochloride | Novartis; Bournonville Eumedica; Merck; Wander |
| Novesinol | Oxybuprocaine Hydrochloride | Novartis |
| Oftalmocaina | Oxybuprocaine Hydrochloride | Allergan |
| Oftan Obucain | Oxybuprocaine Hydrochloride | Santen Pharmaceutical |
| Oxbarukain | Oxybuprocaine Hydrochloride | Chauvin Ankerpharm |
| Oxinest | Oxybuprocaine Hydrochloride | Latinofarma Indistrias Farmaceuticas |